concept

LCN2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LCN2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

217Connections

1Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	LCN2
Key Genes/Proteins	Actin, ALZHEIMER, ALZHEIMER'S DISEASE, ANXIETY, APOPTOSIS, App
Related Diseases	Als, ALS, Alzheimer
Related Pathways	Apoptosis
Linked Hypotheses	1 hypotheses

Wiki Pages (1)

Knowledge base pages for this entity

CLCN2 Gene

gene · 985 words

→

Pathway Diagram

graph TD
    LCN2["LCN2"]
    style LCN2 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
    LCN2 -.->|"inhibits"| Autophagy["Autophagy"]
    LCN2 -->|"binds"| ATG4B([ATG4B])
    LCN2 -.->|"inhibits"| Macroautophagy["Macroautophagy"]
    LCN2 -->|"promotes"| astrocyte_senescence["astrocyte senescence"]
    LCN2 -->|"regulates"| LC3_II([LC3-II])
    LCN2 -->|"activates"| Inflammasome_Ferroptosis["Inflammasome-Ferroptosis"]
    LCN2 -->|"mediates"| Ferroptosis["Ferroptosis"]
    LCN2 -->|"contributes to"| Dry_AMD["Dry AMD"]
    LCN2 -.->|"biomarker for"| Stevens_Johnson_Syndrome["Stevens-Johnson Syndrome"]
    LCN2 -.->|"inhibits"| autophagy["autophagy"]
    YY1([YY1]) -->|"regulates"| LCN2
    ATG4B -->|"interacts"| LCN2
    PYROPTOSIS([PYROPTOSIS]) -->|"activates"| LCN2
    STROKE([STROKE]) -->|"activates"| LCN2
    APOPTOSIS([APOPTOSIS]) -->|"activates"| LCN2
    CSF1([CSF1]) -->|"activates"| LCN2
    RNA([RNA]) -->|"activates"| LCN2
    FERROPTOSIS([FERROPTOSIS]) -->|"activates"| LCN2
    ASTROCYTE([ASTROCYTE]) -->|"activates"| LCN2
    ADORA1([ADORA1]) -->|"activates"| LCN2

Outgoing (167)

Target	Relation	Type	Str
Astrocyte Pyroptosis	mediates	process	0.95
Tunnel Nanotube-Mediated Mitochondrial Transfer	suppresses	process	0.95
Neuronal Dysfunction	causes	phenotype	0.95
Autophagy	inhibits	process	0.90
NLRP3 Inflammasome	activates	pathway	0.90
Dry Age-Related Macular Degeneration	associated_with	disease	0.90
ATG4B	binds	protein	0.90
Astrocytes	expressed_in	cell_type	0.90
Cerebral Ischemia/Reperfusion Injury	contributes_to	disease	0.90
Ferroptosis	regulates	process	0.90
Astrocyte Activation	promotes	process	0.90
Lung Tumor Growth	promotes	phenotype	0.90
Macroautophagy	inhibits	process	0.88
astrocyte senescence	promotes	process	0.88
Lung Metastasis	promotes	phenotype	0.86
Non-Small Cell Lung Cancer	drives	disease	0.85
Ferroptosis	mediates	process	0.85
Inflammasome-Ferroptosis	activates	pathway	0.85
INFLAMMATION	mediates	process	0.85
24p3R	binds	receptor	0.85
LC3-II	regulates	protein	0.85
iron homeostasis	regulates	process	0.85
Memory Impairment	promotes	phenotype	0.85
ferroptosis	promotes	process	0.85
Tumor Growth	promotes	phenotype	0.84
iron metabolism	regulates	pathway	0.80
Dry AMD	contributes_to	disease	0.80
inflammation	promotes	process	0.75
autophagy	inhibits	pathway	0.72
ATG4B	interacts_with	protein	0.72
HMGB1	activates	protein	0.70
NRF2	inhibits	protein	0.70
blood-brain barrier	inhibits	cell_type	0.70
Als	activates	disease	0.65
Pyroptosis	activates	disease	0.65
Necroptosis	activates	disease	0.65
Macular Degeneration	activates	disease	0.65
Stroke	activates	disease	0.65
Inflammation	inhibits	disease	0.65
ALS	activates	disease	0.65
Cancer	biomarker_for	disease	0.65
Retinopathy	contributes_to	disease	0.65
Diabetes	contributes_to	disease	0.65
Alzheimer	activates	disease	0.65
Neuroinflammation	inhibits	disease	0.65
Multiple Sclerosis	expressed_in	disease	0.65
Senescence	activates	disease	0.65
iron_homeostasis	regulates	pathway	0.64
dry_AMD	associated_with	disease	0.64
ferroptosis	activates	pathway	0.64

Incoming (50)

Source	Relation	Type	Str
SATB2	associated_with	gene	0.95
Bezafibrate	downregulates	drug	0.90
YY1	regulates	protein	0.90
ADORA1	promotes	receptor	0.90
Seizures	upregulates	phenotype	0.90
H3K9 Lactylation	upregulates	process	0.90
Lactate	upregulates	compound	0.80
EPILEPSY	associated_with	gene	0.80
EPILEPSY	activates	gene	0.70
GSDMD	associated_with	gene	0.60
HMGB1	activates	gene	0.60
AUTOPHAGY	activates	gene	0.60
HDAC3	activates	gene	0.60
GSDMD	activates	gene	0.60
ATG4B	interacts_with	gene	0.60
APOPTOSIS	activates	gene	0.60
CSF1	activates	gene	0.60
RNA	activates	gene	0.60
FERROPTOSIS	activates	gene	0.60
CHI3L1	activates	gene	0.60
MMP9	activates	gene	0.60
P53	inhibits	gene	0.60
EXOSOMES	activates	gene	0.60
ATG4B	regulates	gene	0.60
LC3	regulates	gene	0.60
KRAS	biomarker_for	gene	0.60
GJA1	biomarker_for	gene	0.60
PYROPTOSIS	activates	gene	0.60
STROKE	activates	gene	0.60
SIRT3	activates	gene	0.60
ATP	activates	gene	0.60
EGFR	activates	gene	0.60
MTDNA	activates	gene	0.60
S100A8	expressed_in	gene	0.60
COX2	activates	gene	0.60
S100A9	expressed_in	gene	0.60
TFAM	activates	gene	0.60
OSMR	expressed_in	gene	0.60
GFAP	inhibits	gene	0.60
GFAP	activates	gene	0.60
MTOR	activates	gene	0.60
DNA	activates	gene	0.60
ADORA1	activates	gene	0.60
ALZHEIMER	activates	gene	0.60
TAU	activates	gene	0.60
ASTROCYTE	activates	gene	0.60
MEF2C	activates	gene	0.60
ARG1	activates	gene	0.60
IL-10	activates	gene	0.60
MAPT	activates	gene	0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss	0.508	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning LCN2 in their description or question text

No additional research found